Inpharamo will Facilitate Clinerion into Mexican Clinical Research Market


Applied Clinical Trials

Inpharamo, a subsidiary of Semicrol, has signed a collaboration agreement to support the entry of the Swiss company, Clinerion. The partnership is dedicated to optimizing the identification of patients who are candidates for participation in clinical trials in Mexico.

For more information, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.